Align 3-methyl-2-oxobutanoate:ferredoxin oxidoreductase (EC 1.2.7.7) (characterized)
to candidate WP_083438777.1 AKL27_RS01445 indolepyruvate ferredoxin oxidoreductase
Query= reanno::Cup4G11:RR42_RS19540 (1197 letters) >NCBI__GCF_001189915.1:WP_083438777.1 Length = 1208 Score = 1314 bits (3400), Expect = 0.0 Identities = 686/1197 (57%), Positives = 850/1197 (71%), Gaps = 41/1197 (3%) Query: 2 NAPLTPPVSDAIRRALANVSLEDKYTLERGRVYISGTQALVRLPMLQRERDRAAGLNTAG 61 +AP P S LANVSL+DKYT G +++SG QALVRLP+LQ+ RDR AGLNTAG Sbjct: 32 HAPSIAPAS------LANVSLDDKYTATSGLIFLSGIQALVRLPLLQQIRDRQAGLNTAG 85 Query: 62 FISGYRGSPLGALDQSLWKAKQHLAAHDIVFQAGLNEDLAATSVWGSQQVNMYPDARFEG 121 FISGYRGSPLG LD++LWKA++HL AH + FQ G NED+AAT+VWG+QQV++ A+++G Sbjct: 86 FISGYRGSPLGGLDEALWKAQKHLDAHQVKFQPGTNEDMAATAVWGTQQVDLIGPAKYDG 145 Query: 122 VFGMWYGKGPGVDRTSDVFKHANSAGSSRHGGVLVLAGDDHAAKSSTLAHQSEHIFKACG 181 VF MWYGKGPGVDR DV KH N AG+S GGVL++AGDDH A SSTL HQS+HIF A Sbjct: 146 VFAMWYGKGPGVDRCGDVLKHMNHAGTSAKGGVLLVAGDDHGAYSSTLPHQSDHIFSASM 205 Query: 182 LPVLYPSNVQEYLDYGLHAWAMSRYSGLWVSMKCVTDVVESSASVELDPHRVEIVLPQDF 241 +P+LYP NVQEYLD GLH WAMSR+SG V K + D VESSASV+ DP RVEI P DF Sbjct: 206 IPMLYPCNVQEYLDLGLHGWAMSRFSGCTVGFKALADTVESSASVDADPFRVEIKYPPDF 265 Query: 242 ILPPGGLNIRWPDPPL-----EQEARLLDYKWYAGLAYVRANKIDRIEIDSPHARFGIMT 296 ++P GGLN R L +QEA + DYK YA LAY RANK++R+ IDSP AR GI+ Sbjct: 266 VMPEGGLNARLSTDTLGVQARKQEALMQDYKIYAALAYARANKLNRVMIDSPKARLGIIA 325 Query: 297 GGKAYLDTRQALANLGLDDETCARIGIRLYKVGCVWPLEAHGARAFAEGLQEILVVEEKR 356 GK+YLD +AL+ LG+D+ A IG+RL+KV WPLE G R FA+GL EILVVEEKR Sbjct: 326 SGKSYLDVLEALSELGIDESFAADIGLRLFKVAMPWPLEPEGVREFAQGLDEILVVEEKR 385 Query: 357 QIMEYALKEELYNWRDDVRPKVYGKFDEKDNAGGEWSIPQSNWLLPAHYELSPAIIARAI 416 Q++EY LKE+LYNWRDDVRP+V GKFDEK GEW P+ WLL + + S A IAR I Sbjct: 386 QMVEYQLKEQLYNWRDDVRPRVIGKFDEK----GEWVAPRGEWLLTSKADFSVAQIARVI 441 Query: 417 ATRLDKFELPADVRARIAARIAVIEAKEKAMAVPRVAAERKPWFCSGCPHNTSTNVPEGS 476 A R+ +F +D+ I AR+A ++AK+ + R ++CSGCPHNTST VPEGS Sbjct: 442 AARIARFH-TSDL---IKARLAFLDAKDAVLTKAVNTPPRPAYYCSGCPHNTSTKVPEGS 497 Query: 477 RALAGIGCHYM-TVWMDRSTSTFSQMGGEGVAWIGQAPFAGDKHVFANLGDGTYFHSGLL 535 ALAGIGCH M T + MGGEG WIGQAPF+ HVFANLGDGTYFHSG L Sbjct: 498 FALAGIGCHVMATAIYPEFNKLTTHMGGEGAPWIGQAPFSRIPHVFANLGDGTYFHSGYL 557 Query: 536 AIRASIAAGVNITYKILYNDAVAMTGGQPIDGKLSVQDVANQVAAEGARKIVVVTDEPEK 595 AIRA++AA VN+TYKILYNDAVAMTGGQP+DG SV +A Q+AAEG +I +V+++ + Sbjct: 558 AIRAAVAAKVNMTYKILYNDAVAMTGGQPVDGTTSVPMIAQQMAAEGITRIALVSEDITR 617 Query: 596 YSAAIKLPQGVEVHHRDELDRIQRELREVPGATILIYDQTCATEKRRRRKRGTYPDPAKR 655 YS LP V VH R ++D IQRELREV G +++IYDQTCA EKRRRRK+G YPDP +R Sbjct: 618 YSDRSNLPALVTVHDRKDMDAIQRELREVSGVSVIIYDQTCAAEKRRRRKKGEYPDPDQR 677 Query: 656 AFINDAVCEGCGDCSVKSNCLSVEPLETELGTKRQINQSSCNKDFSCVNGFCPSFVTAEG 715 FIN+AVCEGCGDC V+SNC S+ PLETE G KR I+QSSCNKD+SCV GFCPSFVT G Sbjct: 678 LFINEAVCEGCGDCGVQSNCTSILPLETEFGRKRAIDQSSCNKDYSCVKGFCPSFVTVTG 737 Query: 716 AQVKKPERHGV----SMDNLPALPQPALPGLEHPYGVLVTGVGGTGVVTIGGLLGMAAHL 771 ++KK + GV S+D+ ALP+P +PG + P+ +L+ G+GGTGV+TIG L+GMAAHL Sbjct: 738 GKLKK-SKTGVTSKDSVDDFGALPEPVIPGCDTPFNILINGIGGTGVITIGALMGMAAHL 796 Query: 772 ENKGVTVLDMAGLAQKGGAVLSHVQIAAHPDQLHATRIAMGEADLVIGCDAIVSAIDDVI 831 E KG +VLDM G++QK G+V SHV+IA P + A RIA GEADL++GCD + + D I Sbjct: 797 EGKGASVLDMTGMSQKNGSVTSHVRIAQTPQAIRAQRIATGEADLILGCDMLTAGSHDAI 856 Query: 832 SKTQVGRTRAIVNTAQTPTAEFIKNPKWQFPGLSAEQDVRNAVGEACDFINASGLAVALI 891 SK + GRTRA+VNT Q P +F KNP W+FP + +VG++ DFI+AS LA AL+ Sbjct: 857 SKMRPGRTRAVVNTHQQPPGQFAKNPDWEFPFAEVRALIEESVGQSADFIDASRLATALM 916 Query: 892 GDAIFTNPLVLGYAWQKGWLPLSLDALVRAIELNGTAVEKNKAAFDWGRHMAHDPEHVLS 951 GD+I TN +LGYAWQ+G LPL+ AL+RAIE+NG AVE NK +F WGR A D L+ Sbjct: 917 GDSIATNLFMLGYAWQRGELPLTEAALLRAIEMNGVAVESNKKSFLWGRRAAVD----LA 972 Query: 952 LTGKLRNTAEGAEVVKLPTSSGALLEKLIAHRAEHLTAYQDAAYAQTFRDTVSRVRAAES 1011 ++ A+ V+++P + L+KL+ R LT YQD YA F V +VR AE Sbjct: 973 RVERIAVPAQPV-VLRMPET----LDKLLTRRVAFLTGYQDERYAAGFAAVVQQVRQAE- 1026 Query: 1012 ALVGNGKPLPLTEAAARNLSKLMAYKDEYEVARLYTDPIFLDKLRNQFEGEPGRDYQLNF 1071 A++G G L L A ARNLSKLMAYKDEYEVARLYTD F L+ QFEG DY+L+F Sbjct: 1027 AVLGQGDKLSL--AVARNLSKLMAYKDEYEVARLYTDGSFTQHLQQQFEG----DYKLSF 1080 Query: 1072 WLAPPLMAKRDEKGHLVKRRFGPSTMKLFGVLAKLKGLRGGVFDVFGKTAERRTERALIG 1131 LAPPL+AK+D +G L+K ++G M +F VLAKL+ LRG D+FG T ER+ ER L Sbjct: 1081 NLAPPLLAKKDAQGRLLKTQYGAWIMPVFRVLAKLRFLRGSKLDIFGYTEERQMERRLAL 1140 Query: 1132 EYRALLEELTRGLSAANHATAITLASLPDDIRGFGHVKDDNLAKVRTRWTALLEQFR 1188 EYR + L L A N A AI +A LPD +RGFGHVKD + +++T LL +FR Sbjct: 1141 EYRNTVLALLPQLRAGNLALAIEIAQLPDRVRGFGHVKDKAVLEMQTAQQDLLRRFR 1197 Lambda K H 0.319 0.135 0.407 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 3200 Number of extensions: 127 Number of successful extensions: 9 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 1197 Length of database: 1208 Length adjustment: 47 Effective length of query: 1150 Effective length of database: 1161 Effective search space: 1335150 Effective search space used: 1335150 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 59 (27.3 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory